The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Gardasil 9



Merck Sharp & Dohme BV,EU/1/15/1007/001-003

Main Information

Trade NameGardasil 9
Active SubstancesHpv type 6 l1 protein
Hpv type 11 l1 protein
Hpv 16 l1 protein
Hpv 18 l1 protein
Hpv type 31 l1 protein
Hpv type 33 l1 protein
Hpv type 45 l1 protein
Hpv type 52 l1 protein
Hpv type 58 l1 protein
Dosage FormSuspension for injection
Licence HolderMerck Sharp & Dohme BV,
Licence NumberEU/1/15/1007/001-003

Group Information

ATC CodeJ07B VIRAL VACCINES

Status

License statusAuthorised
Licence Issued10/06/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back